- Clinical efficacy and compliance of dupilumab therapy in adolescent and adult patients with atopic dermatitis in real clinical practice: An analysis of data from a single allergy clinic in Korea
-
Lee Y, Kim ME, Nahm DH
- KMID: 2541973
- Allergy Asthma Respir Dis.
- 2023 Apr;11(2):82-92.
- doi: 10.4168/aard.2023.11.2.82
Purpose: Dupilumab (a monoclonal antibody to interleukin-4 receptor alpha) is the first biological agent approved for the treatment of moderate-to-severe atopic dermatitis (AD). We evaluated the clinical efficacy and compliance... -
- CITED
-
- Close
- SHARE
-
- Close
- Causes of food allergy according to age and severity: A recent 10-year retrospective study from a single tertiary hospital
-
Lee E, Jeong K, Shin YS, Nahm DH, Park HS, Choi HN, Yoon J, Ye YM, Lee S
- KMID: 2500182
- Allergy Asthma Respir Dis.
- 2020 Apr;8(2):80-88.
- doi: 10.4168/aard.2020.8.2.80
Purpose: Recent studies of food allergy (FA) at all ages are scanty in Korea. We performed this study to better understand severity-related and age-stratified causes of FA from infants to... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety of Ultra-rush Schedule of Subcutaneous Allergen Immunotherapy With House Dust Mite Extract Conducted in an Outpatient Clinic in Patients With Atopic Dermatitis and Allergic Rhinitis
-
Lee SH, Kim ME, Shin YS, Ye YM, Park HS, Nahm DH
- KMID: 2459188
- Allergy Asthma Immunol Res.
- 2019 Nov;11(6):846-855.
- doi: 10.4168/aair.2019.11.6.846
PURPOSE: Ultra-rush schedule of subcutaneous allergen immunotherapy (UR-SCIT) administering maximum maintenance dose of allergen extract within one day can save time and effort for allergen immunotherapy in patients with allergic... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors Associated with Adherence to Allergen Specific Subcutaneous Immunotherapy
-
Lee JH, Lee SH, Ban GY, Ye YM, Nahm DH, Park HS, Shin YS
- KMID: 2446963
- Yonsei Med J.
- 2019 Jun;60(6):570-577.
- doi: 10.3349/ymj.2019.60.6.570
PURPOSE: Allergen-specific immunotherapy (AIT) is known to be the only therapeutic modality to alter the natural course of allergic diseases. However, at least 3 years of treatment is recommended for... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic Effect of Omalizumab in Severe Asthma: A Real-World Study in Korea
-
Lee JH, Lee HY, Jung CG, Ban GY, Shin YS, Ye YM, Nahm DH, Park HS
- KMID: 2402971
- Allergy Asthma Immunol Res.
- 2018 Mar;10(2):121-130.
- doi: 10.4168/aair.2018.10.2.121
PURPOSE: Omalizumab, an anti-immunoglobulin E (IgE) monoclonal antibody, has proved to be effective for the treatment of severe asthma. However, there is no direct evidence of effectiveness of omalizumab in... -
- CITED
-
- Close
- SHARE
-
- Close
- A Retrospective Study of Clinical Response Predictors in Subcutaneous Allergen Immunotherapy With House Dust Mites for Allergic Rhinitis
-
Lee JH, Kim SC, Choi H, Jung CG, Ban GY, Shin YS, Nahm DH, Park HS, Ye YM
- KMID: 2428846
- Allergy Asthma Immunol Res.
- 2018 Jan;10(1):18-24.
- doi: 10.4168/aair.2018.10.1.18
PURPOSE: House dust mites (HDM) are major allergens that cause allergic rhinitis (AR). Allergen-specific subcutaneous immunotherapy (SCIT) has been shown to be clinically beneficial in many clinical trials. Such trials,... -
- CITED
-
- Close
- SHARE
-
- Close
- Linguistic adaptation of the rhinitis control assessment test in Korean
-
Kim MA, Ye YM, Ban GY, Shin YS, Nahm DH, Park HS
- KMID: 2387648
- Allergy Asthma Respir Dis.
- 2017 Jul;5(4):205-210.
- doi: 10.4168/aard.2017.5.4.205
PURPOSE: Allergic rhinitis is one of the most common chronic diseases that affect in sleep, fatigue, headache, impaired cognition, and performances at work or school. Monitoring rhinitis control is important,... -
- CITED
-
- Close
- SHARE
-
- Close
- Subcutaneous Immunotherapy for Allergic Asthma in a Single Center of Korea: Efficacy, Safety, and Clinical Response Predictors
-
Lee JH, Kim SC, Choi H, Jung CG, Ban GY, Shin YS, Nahm DH, Park HS, Ye YM
- KMID: 2379607
- J Korean Med Sci.
- 2017 Jul;32(7):1124-1130.
- doi: 10.3346/jkms.2017.32.7.1124
Allergen-specific immunotherapy is the only causal treatment for allergic diseases. However, the efficacy of immunotherapy may vary around the world due to differences in climate, the nature of aero-allergens and... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Efficacy of Subcutaneous Allergen Immunotherapy in Patients with Atopic Dermatitis
-
Nahm DH, Kim ME, Kwon B, Cho SM, Ahn A
- KMID: 2427160
- Yonsei Med J.
- 2016 Nov;57(6):1420-1426.
- doi: 10.3349/ymj.2016.57.6.1420
PURPOSE: The clinical usefulness of subcutaneous allergen immunotherapy (SCIT) in the treatment of atopic dermatitis (AD) is still controversial. We analyzed the clinical efficacy of SCIT in patients with AD... -
- CITED
-
- Close
- SHARE
-
- Close
- Multicenter questionnaires on the current management of atopic dermatitis in Korea
-
Lee DH, Doh EJ, Lee JY, Park Y, Oh JW, Lee MH, Hong SJ, Lee SY, Park JS, Nahm DH, Yum HY, KAACI Work Group on Severe/Recalcitrant Atopic Dermatitis
- KMID: 2346756
- Allergy Asthma Respir Dis.
- 2016 Jul;4(4):271-275.
- doi: 10.4168/aard.2016.4.4.271
PURPOSE: The effective management of atopic dermatitis (AD) adjusted to individual clinical courses and demands can be challenging to both patients and physicians. Understanding of actual situations, experienced and perceived... -
- CITED
-
- Close
- SHARE
-
- Close
- Autologous Immunoglobulin Therapy in Patients With Severe Recalcitrant Atopic Dermatitis: Long-Term Changes of Clinical Severity and Laboratory Parameters
-
Nahm DH, Ahn A, Kim ME, Cho SM, Park MJ
- KMID: 2165921
- Allergy Asthma Immunol Res.
- 2016 Jul;8(4):375-382.
- doi: 10.4168/aair.2016.8.4.375
This report evaluated long-term changes in clinical severity and laboratory parameters in 3 adult patients with severe recalcitrant atopic dermatitis (AD) who were treated with intramuscular injections of 50 mg... -
- CITED
-
- Close
- SHARE
-
- Close
- Associations of Atopic Dermatitis With Obesity and Unmarried Status in Young Adults: Evidence for Atopic Dermatitis as a Life-Style Disorder With High Social Impact
-
Nahm DH
- KMID: 2165923
- Allergy Asthma Immunol Res.
- 2016 Mar;8(2):89-91.
- doi: 10.4168/aair.2016.8.2.89
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Favorable outcome of omalizumab treatment in a patient with idiopathic anaphylaxis
-
Ban GY, Yang EM, Kim JH, Shin YS, Ye YM, Nahm DH, Park HS
- KMID: 2218651
- Allergy Asthma Respir Dis.
- 2015 Sep;3(5):380-383.
- doi: 10.4168/aard.2015.3.5.380
Anaphylaxis is a severe and life-threatening systemic reaction. Despite the extensive evaluation to determine the cause, 30%-60% of cases of anaphylaxis in adults remain idiopathic. Recently, omalizumab treatment has been... -
- CITED
-
- Close
- SHARE
-
- Close
- Personalized Immunomodulatory Therapy for Atopic Dermatitis: An Allergist's View
-
Nahm DH
- KMID: 2171489
- Ann Dermatol.
- 2015 Aug;27(4):355-363.
- doi: 10.5021/ad.2015.27.4.355
The current standard medical therapy for atopic dermatitis (AD) mainly focuses on symptomatic relief by controlling skin inflammation with topical corticosteroids and/or topical calcineurin inhibitors. However, the clinical efficacy of... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunologic Evaluation of Patients with Cefotetan-Induced Anaphylaxis
-
Nam YH, Hwang EK, Ban GY, Jin HJ, Yoo HS, Shin YS, Ye YM, Nahm DH, Park HS, Lee SK
- KMID: 2260469
- Allergy Asthma Immunol Res.
- 2015 May;7(3):301-303.
- doi: 10.4168/aair.2015.7.3.301
Cefotetan is a commonly prescribed second-generation cephalosporin that acts against a wide range of bacteria. However, cefotetan-induced hypersensitivity has rarely been reported. We report 2 cases of cefotetan-induced anaphylaxis with... -
- CITED
-
- Close
- SHARE
-
- Close
- Present and future of allergen immunotherapy for allergic diseases
-
Nahm DH
- KMID: 2195039
- J Korean Med Assoc.
- 2015 May;58(5):433-440.
- doi: 10.5124/jkma.2015.58.5.433
Current pharmacological therapies for allergic diseases can improve clinical symptoms but cannot change their long-term clinical course. There is an unmet need for a curative treatment for allergic diseases. Allergen... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical features of elderly chronic urticaria
-
Ban GY, Kim MY, Yoo HS, Nahm DH, Ye YM, Shin YS, Park HS
- KMID: 2070138
- Korean J Intern Med.
- 2014 Nov;29(6):800-806.
- doi: 10.3904/kjim.2014.29.6.800
BACKGROUND/AIMS: Chronic urticaria (CU) is defined as itchy wheals lasting 6 weeks or more. As the aged population increases worldwide, it is essential to identify the specific features of this... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Characteristics of Angioedema With Eosinophilia
-
Cho HJ, Yoo HS, Kim MA, Shin YS, Ye YM, Nahm DH, Kim JH, Choi JH, Park SY, Park HS
- KMID: 2260218
- Allergy Asthma Immunol Res.
- 2014 Jul;6(4):362-365.
- doi: 10.4168/aair.2014.6.4.362
Angioedema with eosinophilia (AE) is a very rare allergy disease, case reports of which have been published sporadically since 1984. Here, we retrospectively analyzed the clinical features of 10 AE... -
- CITED
-
- Close
- SHARE
-
- Close
- The Prevalence of Serum Specific IgE to Superantigens in Asthma and Allergic Rhinitis Patients
-
Liu JN, Shin YS, Yoo HS, Nam YH, Jin HJ, Ye YM, Nahm DH, Park HS
- KMID: 2260690
- Allergy Asthma Immunol Res.
- 2014 May;6(3):263-266.
- doi: 10.4168/aair.2014.6.3.263
Staphylococcus aureus is the most common bacterium present in upper respiratory tract, and the toxins it produced are involved in allergic inflammation pathogenesis. In this study, we investigated the clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Codeine Induced Anaphylaxis via Oral Route
-
Yoo HS, Yang EM, Kim MA, Hwang SH, Shin YS, Ye YM, Nahm DH, Park HS
- KMID: 2166952
- Allergy Asthma Immunol Res.
- 2014 Jan;6(1):95-97.
- doi: 10.4168/aair.2014.6.1.95
Codeine is widely prescribed in clinical settings for the relief of pain and non-productive coughs. Common adverse drug reactions to codeine include constipation, euphoria, nausea, and drowsiness. However, there have... -
- CITED
-
- Close
- SHARE
-
- Close
